Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells

作者: Wei Cui , Stephen L Chen , Ke-Qin Hu , None

DOI:

关键词:

摘要: Developing a quantifiable in vitro model of steatosis is critical understanding the pathogenesis nonalcoholic fatty liver disease (NAFLD) and searchingfor effective therapies. Using an ORO-based colorimetric measurement, we developed convenient assay to qualify degree OA-induced HepG2 cells. We demonstrated that absence exogenous inflammatory mediators, was associated with increased production secretion tumor necrosis factor alpha decreased expression peroxisome proliferators-activated receptor α also lipid peroxidation, apoptosis, but proliferation these The peroxidation related SOD-1, free radical scavenger enzyme; while apoptosis active caspase-9. mediated by p27 unchanged alanine transaminase (ALT) level culture medium, indicating alters cell cycle progression without direct toxicity In conclusion, present study accurately quantifies results series pathophysilogical changes cells, pathogenic roles hepatocytes NAFLD.

参考文章(44)
Freida L. Carson, Christa Hladik, Histotechnology: A Self-Instructional Text ,(1990)
Mikyung Sung, Ikhwan Kim, Miyoung Park, Youngmi Whang, Myoungsook Lee, Differential Effects of Dietary Fatty Acids on the Regulation of CYP2E1 and Protein Kinase C in Human Hepatoma HepG2 Cells Journal of Medicinal Food. ,vol. 7, pp. 197- 203 ,(2004) , 10.1089/1096620041224157
Gianluca Svegliati-Baroni, Cinzia Candelaresi, Stefania Saccomanno, Gianna Ferretti, Tiziana Bachetti, Marco Marzioni, Samuele De Minicis, Liliana Nobili, Renata Salzano, Alessia Omenetti, Deborah Pacetti, Soeren Sigmund, Antonio Benedetti, Alessandro Casini, A Model of Insulin Resistance and Nonalcoholic Steatohepatitis in Rats The American Journal of Pathology. ,vol. 169, pp. 846- 860 ,(2006) , 10.2353/AJPATH.2006.050953
Andrew I. Shulman, David J. Mangelsdorf, Retinoid x receptor heterodimers in the metabolic syndrome. The New England Journal of Medicine. ,vol. 353, pp. 604- 615 ,(2005) , 10.1056/NEJMRA043590
Jay D. Horton, Jeffrey D. Browning, Molecular mediators of hepatic steatosis and liver injury Journal of Clinical Investigation. ,vol. 114, pp. 147- 152 ,(2004) , 10.1172/JCI22422
Yeon Seok Seo, Ji Hoon Kim, Nam Young Jo, Kyung Mook Choi, Sei Hyun Baik, Jong-Jae Park, Jae Seon Kim, Kwan Soo Byun, Young-Tae Bak, Chang Hong Lee, AeRee Kim, Jong Eun Yeon, PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes Journal of Gastroenterology and Hepatology. ,vol. 23, pp. 102- 109 ,(2006) , 10.1111/J.1440-1746.2006.04819.X
Karima Begriche, Anissa Igoudjil, Dominique Pessayre, Bernard Fromenty, Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it Mitochondrion. ,vol. 6, pp. 1- 28 ,(2006) , 10.1016/J.MITO.2005.10.004
Alexander Khoruts, Laura Stahnke, Craig J. McClain, George Logan, John I. Allen, Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients Hepatology. ,vol. 13, pp. 267- 276 ,(1991) , 10.1002/HEP.1840130211